/Investor DB

GV (Google Ventures)

Corporate VCoperating company · company profile

Mountain View · Seed–Late Stage · 126 people tracked

Also known as Google Ventures · GV · Tetrad Capital

Find your way into GV (Google Ventures)

Sign up to see every warm intro you have to GV (Google Ventures)

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the GV (Google Ventures) team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

GV has invested in AI and machine learning since its founding, with early ML bets like Flatiron Health (2012) and core AI investments beginning in 2016 with Lattice (later acquired by Apple for Siri's Knowledge Graph). Its global portfolio spans more than 100 AI companies across the full AI stack — infrastructure, life sciences, and applications — including companies such as Vercel, Lightmatter, Harvey, OpenEvidence, Synthesia, Thinking Machines, and Isomorphic Labs. GV believes the most valuable AI companies will reduce cost and complexity, prioritize real-world utility over sheer scale, and unlock exponential innovation across every domain.

Source: firm website, verified Sep 27, 2026.

Stage
Seed–Late Stage
Check
$250K – $50M
HQ
Mountain View, CA, US
Leads rounds
Leads
Instruments
Equity
Founded
2009
Last 12 months
63 investments
AUM
$13B
Tracked investments
944
Unicorns
93
IPOs
40
Acquisitions
112

Team · 126 people

from the firm's website & curated & public directories
Gabriel Alatorre· Engineering Partner
Graham Hancock· Content Partner
Greg Dooley· Engineering Partner
John Bui· Engineering Partner
Sam McCauley· Engineering Partner
Zal Bhathena· Engineering Partner
Brendan Bulik-Sullivan· General Partnerin

General partner at GV focused on life sciences investments, interested in therapeutic biotechnology and diagnostics across all stages. Before GV, he worked on applied statistics and machine learning in genetics and biotech at Gritstone Oncology and the Broad Institute, with published research in Nature and Science. He holds a B.A. in mathematics from UC Berkeley and a Ph.D. in statistical genetics from Vrije Universiteit Amsterdam.

David Schenkein· General Partnerin𝕏

Dr. David Schenkein leads GV's life science investment team, where he focuses on therapeutics, diagnostics, medical devices, novel care delivery systems, and payer innovation. He has worked as a hematologist and medical oncologist for over 30 years and previously spent ten years as CEO and board member of Agios Pharmaceuticals, as well as senior roles at Genentech (clinical hematology/oncology) and Millennium Pharmaceuticals (clinical research). He holds a B.A. in chemistry from Wesleyan University and an M.D. from the State University of New York Upstate Medical School.

Issi Rozen· General Partnerin

Issi Rozen is a general partner at GV focused on new company formation and early-stage life sciences investments. A former biotech executive and serial entrepreneur, he co-founded several startups including Verve Therapeutics and previously served as Chief Business Officer at the Broad Institute of MIT and Harvard. He holds an MBA from MIT Sloan and was formerly a jazz guitarist and Berklee College of Music professor.

Karthik Ardhanareeswaran· Partnerin

An investing partner at GV focused on life sciences. Previously a VP and quant at D.E. Shaw developing algorithmic trading strategies, and earlier a stem cell and bioinformatics researcher at the Yale Child Study Center. Holds undergraduate and graduate degrees from Yale in Molecular, Cellular, and Developmental Biology.

Sherry Chao· Partnerin

Sherry Chao is an investing partner at GV, where she focuses on life sciences investments. She previously worked as a private equity investor at Goldman Sachs and as a cancer immunology researcher at the Broad Institute of MIT and Harvard. She holds a Ph.D. in computational biology and a BA in economics from Harvard, as well as an MBA from Harvard Business School.

Tom Hulme· Managing Partnerin𝕏

Tom Hulme is GV's head of Europe and co-lead of its global tech investing team, focusing on startups across fintech, enterprise, AI, science, and consumer applications. He previously served as design director at IDEO, where he led the firm's global startup efforts and founded OpenIDEO, and earlier was managing director of sports car manufacturer Marcos and founder of magnetic filter startup Magnom. He holds a first-class physics degree from the University of Bristol and an MBA from Harvard Business School.

Anika Gupta· Principalin𝕏

Anika Gupta is a principal at GV focused on biotech companies developing new therapeutics. She has prior experience in biotech formation and developed bioinformatics frameworks for patient stratification at Foundation Medicine and immunotherapy prediction at Merck. She holds a Ph.D. in bioinformatics and genomics from Harvard University and the Broad Institute, with doctoral research in single-cell genomics and autoimmune disease genetics, and a B.S. in Computer Science and Molecular Biology from MIT.

Cathy Friedman· Executive Venture Partnerin

Cathy Friedman is an Executive Venture Partner at GV with nearly 40 years of experience across banking, technology, and life sciences. She previously spent nearly 24 years at Morgan Stanley, where she was a managing director and co-head of the biotech practice, and later worked as an independent financial consultant and board member. At GV she is a senior member of the investing team and advises the firm's life sciences portfolio alongside Dan Lynch.

Dan Lynch· Executive Venture Partnerin𝕏

Dan Lynch joined GV in 2021 as an Executive Venture Partner, advising life sciences CEOs and executives while investing in biopharmaceutical companies. Since 2007 he has served as executive chair or board member for numerous biotech firms, and he previously was CEO and CFO of ImClone Systems, where he helped secure FDA approval of the cancer treatment ERBITUX. He also worked at Third Rock Ventures and held financial roles at Bristol-Myers Squibb, and holds a B.A. in mathematics from Wesleyan University and an M.B.A. from the University of Virginia's Darden School.

David Reshef· Venture Partnerin

David Reshef is a computer scientist and physician serving as a venture partner at GV, focusing on machine learning, healthcare, and life sciences investments. He holds an M.D. from Harvard Medical School and a Ph.D. in computer science from MIT, and trained clinically in internal medicine and hematology/oncology.

Scott Biller· Executive Venture Partnerin

Dr. Scott Biller is an Executive Venture Partner at GV with a deep R&D background, having served as Chief Scientific Officer of Agios Pharmaceuticals and held leadership roles at Novartis and Bristol-Myers Squibb. He advises and sits on the boards of several biotech companies including Foghorn, Remix, Rome, and OMass Therapeutics.

Scott Davis· Venture Partner

Scott is a life sciences venture partner at GV and a professor of engineering at Dartmouth College focused on imaging strategies for understanding drug activity and guiding therapy. In a part-time role, he supports startups working on diagnostics and drug delivery platforms, drawing on his biomedical engineering background and prior startup experience.

Sridhar Ramaswamy· Entrepreneur in Residence & Venture Partner𝕏
Abi Joyce· Executive Business Partner
Amy Anton· Talent Partner
Araceli Pacheco· Sr. Financial Analyst
Caleb Langlinais· Financial Analyst
Caroline Walters· Portfolio Operations Partner
Chelsea Kunin· Executive Business Partner
Chris Re· Advisor
Chris Urenda· Head of Legal Operations
Christina Kelleher· Executive Business Partner
Crystal Dela Cruz· Executive Business Partner
Danielle Lewis· Executive Business Partner
David Benjamin· Advisor
Dylan Sorman· People Operations Program Manager
Elizabeth Zeratsky· Associate General Counsel
Francy Troche· Office Manager
Gaurav Singal· Advisor
Gina Novak· Controller
Greg Schacht· Sr. Financial Analyst
Helen Truong· Executive Business Partner
Holly Heafey· Executive Talent Researcher
Irina Umansky· Executive Business Partner
Jane Lebkowski· Advisor
Jennifer Cook· Advisor
Jessica Ashford· Controller
Jonathan Sorger· Advisor
Julia Owens· Advisor
Kaitlin Shavey· Events Manager
Karen Ku· Legal Operations Specialist
Kathy High· Advisor
Kelsey Dowling· Assistant Controller
Kevin Marks· Advisor
Kim Burr· Chief Financial Officer
Lily Johnson· Executive Business Partner
Luke Elder· Sr. Legal Counsel
Maggie Moran· Executive Business Partner
Mandy Stolpa· Partner & Head of Communications
McKenzie Furber· Talent Partner
Megan Klein· Executive Business Partner
Melissa McLaughlin· Advisor
Michael Parker· Executive Business Partner
Mikael Dolsten· Advisor
Mim West· Executive Business Partner
Nancy Thornberry· Advisor
Natalie Sanchez· Assistant Controller
Natalie Schwartz· Head of Marketing
Nate Amchan· Senior Manager, Portfolio Advisor
Nicole Doherty· Executive Business Partner
Nicole Radell· A/EBP Team Manager
Rhys Hughes· Executive Talent Partner
Richard Scheller· Advisor
Rob Wu· Executive Business Partner
Robert Abraham· Advisor
Robert Copeland· Advisor
Robin Teng· Senior Controller
Ryan Spiers· Associate General Counsel
Sal Diaz· Finance Manager
Sierra Warner· Chief People Officer
Stefany Zelaya· Executive Business Partner
Sue Desmond-Hellmann· Advisor
Teni Ajayi· Executive Business Partner
Teri Wisness· Advisor
Victoria Miller· A/EBP Team Manager
Wendy Young· Advisor
Winnie Kimaiga· Executive Business Partner
Yeji Han· Legal Counsel
Zach Brauer· Senior Finance Partner
Zefralyn Guerrero· Administrative Business Partner
Anthony Philippakis· General Partnerin

A physician, genomicist, and data scientist, Philippakis is a general partner at GV investing at the intersection of life sciences and machine learning, with a focus on bringing genome sequencing and data science into clinical medicine. A former cardiologist at Brigham and Women's Hospital, he holds degrees from Yale, Cambridge, and Harvard, and spearheaded GV's incubation of Verve Therapeutics in 2016.

Ben Robbins· General Partnerin𝕏

Ben Robbins is a psychiatrist-turned-investor with an MD/MBA and residency at Massachusetts General Hospital and McLean who leverages serious mental illness experience to evaluate clinical fit and provider workflow impact.

Crystal Huang· General Partnerin𝕏

Crystal Huang is a general partner at GV, focusing on SaaS, infrastructure, and AI, with attention to product- and developer-led adoption. She previously invested at NEA and Notable Capital (formerly GGV) and started her career in technology M&A at Blackstone. She holds a B.A. in Government from Harvard University.

Dave Munichiello· Managing Partnerin𝕏

Dave Munichiello is a GV Managing Partner leading the firm's tech investing team across consumer, enterprise, and frontier areas, with a focus on data platforms, developer tools, infrastructure, and enterprise software. Before GV he was an early executive at Kiva Systems (later Amazon Robotics) and a combat veteran and former U.S. military Captain; he holds an MBA from Harvard Business School and a B.S. from Emory University.

David Krane· CEO & Managing Partnerin𝕏

David Krane leverages a communications and product PR background at Google to personally lead his firm's ~$258M Uber investment and frames deals through a Gen Z parent's dinner-table perspective.

Elena Sakach· Partnerin𝕏

Elena Sakach is an investment partner at GV based in San Francisco, focusing on fintech, software, and artificial intelligence. She previously was a partner at Coatue, where she led investments across fintech and software, and earlier worked in the TMT Investment Banking Division at Goldman Sachs and in TPG's Tech Investing Practice. Originally from the Midwest, she began her career in investment banking on Wall Street.

Erik Nordlander· General Partnerin𝕏

Erik Nordlander combines MIT CS and graduate research in data extraction with Google engineering and tech‑lead experience, leads the New York office, and champions developer, cloud and AI infrastructure founders.

Frédérique Dame· General Partnerin𝕏

Frédérique Dame is a General Partner at GV who focuses on consumer technology and helped establish the firm's Women's Health investing team. Before GV, she led product and engineering at Uber during its rapid scaling period, and earlier worked on social and user-generated content products at Yahoo!, Photobucket, and SmugMug. She holds Master of Science degrees from University College London (Spacecraft Technology and Satellite Communications) and Télécom SudParis (Telecommunications Engineering).

Karim Faris· General Partnerin𝕏

Karim Faris leads investments in enterprise software, big data and security, using pattern recognition in modern data protection—led Cohesity's deal—and champions platforms that make secondary data accessible, analyzable and secure.

KJ Sidberry· Partnerin𝕏

KJ Sidberry is a New York-based investing partner at GV focused on early-stage consumer companies. He previously worked as an investor at Forerunner Ventures and earlier held consulting roles at Accenture and The Boston Consulting Group, where he handled pricing strategy, due diligence, industry analysis, and growth planning. He earned a B.A. in computer science from Harvard University.

Krishna Yeshwant· Managing Partnerin𝕏

Krishna Yeshwant studied computer science at Stanford and co-founded two technology companies early in his career, one acquired by Hewlett-Packard and another by Symantec. He later earned an MD/MBA from Harvard and worked as an attending in internal medicine at Brigham and Women's Hospital before joining Google in 2008, where he helped launch GV and led its early life sciences investing. As an investor he focuses on the full healthcare spectrum, including care delivery, health IT, devices, diagnostics, payor/provider, and therapeutics, and established GV's company incubation program.

Luna Schmid· Partnerin

Luna Schmid is a London-based partner at GV focused on technology investments. She previously served on the investment teams at Summit Partners' Venture Capital Fund and SoftBank's Vision Fund, working on early and late-stage technology investments, and earlier invested in late-stage buyouts at Warburg Pincus. She began her career in investment banking at Morgan Stanley and holds a B.S. in finance and international business from NYU's Stern School of Business, with a minor in computer science and mathematics.

Michael McBride· General Partnerin𝕏

Michael McBride is a General Partner at GV, based in the San Francisco office, where he leads early-stage investments across enterprise technology, including companies built on open-source technologies and AI-driven approaches. Before joining GV, he spent five years as Chief Revenue Officer at GitLab, overseeing sales, marketing, and customer success. Earlier in his career he held sales and product leadership roles at Meraki, Good Technology, Be, Inc., and Lookout, and was a founding executive at Lionside and Starcode Software. He holds a B.S. in Mechanical Engineering and an MBA, both from Stanford.

Mojca Skoberne· Entrepreneur in Residencein

Mojca Skoberne is an Entrepreneur in Residence at GV focused on building organizations and immune-system-based therapies. Prior to GV she held immunology and drug development leadership roles at Cogen/Repertoire Immune Medicines, Gritstone Oncology, and Genocea Biosciences, and holds a Ph.D. in Medical Sciences.

Mounisha Anumolu· Associatein

New York-based GV investor focused on AI across stages and the tech stack. Previously an investment banking analyst at Goldman Sachs in the TMT division working on enterprise software M&A, and interned at the Brookings Institution; holds a degree in Economics, Computer Science, and Public Policy from Dartmouth College.

Nicole Gaudelli· Entrepreneur in Residencein

A life sciences entrepreneur in residence who joined GV in 2024, focused on the intersection of chemistry and biology and precision genetic medicines. She holds a chemistry Ph.D. from Johns Hopkins, invented the first adenine base editor during her Harvard/Broad Institute postdoc, and previously served as VP of gene editing at Beam Therapeutics.

Rishi Modi· Associatein

Rishi Modi is an investor at GV focused on AI applications and infrastructure from seed to growth stages. Before joining GV in 2024, he was a tech IB analyst at J.P. Morgan and previously worked at Menlo Ventures, CyCognito, SVB Capital, Dell Tech Capital, and Citi Ventures; he studied Business and Data Science at UC Berkeley.

Roni Hiranand· Principalin𝕏

London-based investment principal at GV focused on early and late-stage companies in frontier and enterprise technology. Previously invested at Ant Financial's Bace Capital and Vectr Ventures on early-stage deals, and lectured on food science at the University of Hong Kong, where he earned a BA in History.

Sam Blackman· Entrepreneur in Residencein

Dr. Samuel Blackman is a physician-scientist, pediatric neuro-oncologist, and cancer drug developer who joined GV in 2025 as a life sciences entrepreneur in residence. He co-founded Day One Biopharmaceuticals in 2018 and previously held senior oncology drug development roles at companies including Merck, GlaxoSmithKline, Seattle Genetics, and Juno Therapeutics.

Sangeen Zeb· General Partnerin𝕏

Sangeen Zeb is a general partner at GV, where he concentrates on AI investments. He previously worked as an investor at Founders Circle Capital, helping lead deals in companies including Databricks, Robinhood, and Confluent, and spent over five years at Centerview Capital, where he sourced investments in Affirmed Networks and Sauce Labs. He began his investment career at Summit Partners.

Vidu Shanmugarajah· General Partnerin𝕏

Vidu Shanmugarajah is a Partner at GV (Google Ventures), where he invests in early-stage technology companies across AI, cloud infrastructure, biotech, enterprise, and consumer internet, typically at the Series A through Series B stages. Before entering venture capital, he began his career as a corporate lawyer at Linklaters, working on M&A, restructuring, and financing deals. He later moved into venture capital at Grafton Capital and into growth equity and business strategy at HgCapital. He also founded an online legal services platform called ConnexLaw. He is based in London and focuses on early-stage technology investing.

Ali Goldstein-Norup
Allie Hexner
Ben Seipel
Benjamin Gardiner
Graham Spencer· GV Fellowin𝕏

Graham Spencer, a managing partner, combines first-cycle internet operating experience—co-founding/CTO of Excite.com—with a part-time CTO role at Synapticure and trusteeship at the Santa Fe Institute, merging building and complexity-science insight.

Hriday Chhabria
Jane Cheng
Jessica Lane
Joana Carrasqueira
John Alioto
John Jumper
Juanita Bawagan
Louis Huynh
Naji Barnes-McFarlane
Pauline Cristofari
Ravi Ramachandran
Rosana Kapeller· Advisorin𝕏
Shrestha Basu Mallick
Taylor Marcus

Founder mafia

8 people who came through GV (Google Ventures) went on to found or lead other companies.

What they invest in

from 682 of 944 portfolio companies

AI & Machine Learning ×292SaaS ×185Enterprise Software ×176Healthtech ×149Biotech ×116Digital Health ×85Consumer ×84Data & Infrastructure ×82

HQs:United States×523United Kingdom×26Canada×5Switzerland×5Germany×3France×3

Who they back

founder profiles across 429 portfolio companies
24%
solo founders
104 of 429 mapped founding teams
45%
repeat founders
of 557 founders with career history
~3 yrs
old at investment
median across 263 dated deals

Founding team size:solo founder×1042 founders×1253 founders×834+ founders×117

Where their founders studiedfrom 496 founders with education data

Stanford University ×46University of California, Berkeley ×28Harvard University ×26Massachusetts Institute of Technology ×23Harvard Business School ×17University of Cambridge ×12Duke University ×11Stanford University Graduate School of Business ×11

What their founders studiedfrom 493 founders with field-of-study data

Computer Science ×185Engineering ×114Business & Management ×72Life Sciences ×46Economics ×42Mathematics & Statistics ×26Humanities ×21Medicine ×21

Where their founders worked beforefrom 557 founders with career history

Google ×70Microsoft ×30Stanford University ×27Oracle ×12Cisco ×11Meta ×11OpenAI ×9Apple ×8

Accelerator rootsportfolio companies that came through a program

Y Combinator ×51Techstars ×12Entrepreneur First ×2Plug and Play Ventures ×2

119 founders hold a PhD · 64 hold an MBA (of 534 with degree data) · backed the same founder in 2+ companies: 10 founders

Investments · 944 tracked

founders shown can be your intro path

By year:2026 · 512025 · 572024 · 542023 · 412022 · 522021 · 522020 · 272019 · 172018 · 372017 · 282016 · 152015 · 23504 dated

Prime Medicineprimemedicine.comin𝕏NASDAQ: PRMESeries A · Oct 2019 · $120M✓ verified

Prime Medicine develops one-time genetic therapies using Prime Editing, a gene editing technology developed in David R.

BiotechDeep TechHealthtechMedical Devices

Andrew Anzalone(Founder)inDavid Liu(Co-founder)inAllan Reine(Chief Executive Officer)inMohammed Asmal(Chief Medical Officer)inAnn Lee(Chief Technical Officer)inSvetlana Makhni(Chief Financial Officer)in

Co-investorsARCH Venture PartnersNewpath PartnersF-Prime CapitalOUP (Osage University Partners)Samsara BioCapitalArrive+1 more

1Life HealthcareNasdaq (historical; delisted after acquisition): ONEMAug 2018acquired by Amazon Music · Jul 2022 · $3.9B

1Life Healthcare operated One Medical, a membership-based primary care organization offering in-person clinics and virtual care across the United States.

Digital HealthHealthtechSan Francisco, US

Thomas H. Lee(Founder; former CEO)inAmir Dan Rubin(Former Chair and CEO)Paul S. Kirincich(Executive Officer)inTrent Green(Former CEO)inAndrew S. Diamond(Chief Medical Officer, Amazon One Medical; Head of One Medical Clinical Care Delivery)inRoy Schoenberg(Head of Amazon Health Services)in

Board seatKrishna Yeshwant· per SEC Form D

Co-investorsDag VenturesJ.P. Morgan Asset ManagementMaverick CapitalOak Investment PartnersBenchmarkMaverick Ventures+1 more

Denali Therapeuticsdenalitherapeutics.cominNASDAQ: DNLIMar 2024

Denali Therapeutics develops therapeutics for neurodegenerative diseases.

BiotechHealthtechMedical DevicesSan Francisco, US

Marc Tessier-Lavigne(Founder)inAlexander O. Schuth(Executive Officer)inRyan J. Watts(President, Chief Executive Officer and Director)inCarole Ho(Executive Officer)inSteve E. Krognes(Director)inAlexander Schuth(Founder)

Board seatDavid Schenkein· per SEC Form D

Co-investorsARCH Venture PartnersEcoR1 CapitalF-Prime CapitalForesite CapitalFlagship PioneeringFlagship Ventures

A Place for Momaplaceformom.comin𝕏NASDAQ: GDRXSeries A · Jul 2017 · $20Macquired by Exit Blackstone · Jul 2025 · $2.6B

A Place for Mom is a senior care referral service that helps families find and compare senior living and care options, including assisted living, memory care, independent living, home care, nursing homes, and senior apartments.

ConsumerDigital HealthHealthtechMarketplacesWellness & FitnessVernon Hills, US

Douglas Hirsch(Director)Trevor Bezdek(Co-Chairman & Director)Jonathan Stevens(Executive Officer)Thomas Richards(Executive Officer, Director)Christine Leahy(Executive Officer)Dennis Berger(Executive Officer)

Co-investorsBain Capital Double Impact Fund LPBain Capital Life SciencesBain Capital Tech OpportunitiesBattery VenturesBessemer Venture PartnersBlue Sea Capital+38 more

Alectoralector.comin𝕏NASDAQ: ALECSep 2015

Alector develops therapies targeting neurodegenerative diseases including Alzheimer's, frontotemporal dementia, and Parkinson's disease through protein removal, replacement, and immune cell restoration.

AI & Machine LearningBiotechHealthtechLongevityMedical DevicesSan Francisco, US

Arnon Rosenthal(Ph.D.)inTillman Gerngross(Director)

BoardCarl Gordon(Director)Terry McGuire(Director)in

Co-investorsForesite CapitalMission Bay CapitalMission BiocapitalMRL Ventures FundSV Health InvestorsPolaris Partners

Barinthusbiobarinthusbio.comin𝕏NASDAQ: BRNS

Barinthus Biotherapeutics is a clinical-stage biopharmaceutical company developing antigen-specific immunotherapies designed to guide T cells to treat autoimmune and inflammatory diseases.

BiotechDeep TechHealthtechMedical Devices

Geoffrey Lynn(Chief Scientific Officer)William Enright(Chief Executive Officer & Board Director)Leon Hooftman(Chief Medical Officer)Bill EnrightinAdrian Hill(Founder)Sarah Gilbert(Founder)

Co-investorsFuture Planet CapitalOxford Science EnterprisesGilead SciencesKorea Investment PartnersMilltrust International GroupTencent Holdings+1 more

Beam Therapeuticsbeamtx.comin𝕏NASDAQ: BEAMNov 2018

Beam Therapeutics develops gene-editing medicines, particularly base editors and precision genome editing technologies, to create lifelong cures for patients with serious genetic diseases.

BiotechDeep TechMedical DevicesCambridge, US

David R. Liu(Founder)inJ. Keith Joung(Founder)inFeng Zhang(Founder)David R. Liu, Ph.D.(Founder and Inventor)J. Keith Joung, M.D., Ph.D.(Founder and Inventor)Feng Zhang, Ph.D.(Founder and Inventor)

Co-investorsARCH Venture PartnersDreamers VCEight Roads VenturesF-Prime CapitalForesite CapitalHongShan Capital Group+2 more

Compass Therapeuticscompasstherapeutics.comin𝕏NASDAQ: CMPX

Compass Therapeutics uses proprietary antibody discovery platforms to generate and screen diverse panels of monoclonal and multispecific antibodies, aiming to identify synergistic therapeutic combinations.

BiotechHealthtechCambridge, US

Schuetz Thomas(Executive Officer, Director)inErrik Anderson(Executive Officer, Director)inThomas J. Schuetz(Executive Officer, Director)inVered Bisker-Leib(Executive Officer)inBarry Shin(Chief Financial Officer)inNeil Lerner(Senior Vice President, Chief Accounting Officer)in

Co-investorsAlumni VenturesBioBritF-Prime CapitalForesite CapitalOrbiMedvenBio Partners+3 more

DocuSigndocusign.comin𝕏NASDAQ: DOCU

DocuSign provides AI-powered agreement management, electronic signature, and contract lifecycle management solutions for enterprises.

Enterprise SoftwareLegalTechSaaSSan Francisco, US

Tom Gonser(Founder)inMike Dinsdale(Executive Officer)inNeil Hudspith(Executive Officer)inReggie Davis(Executive Officer)inKeith Krach(Executive Officer, Director)inAllan Thygesen(President, Chief Executive Officer)in

Co-investorsAccelAkkadian VenturesArtisanal VenturesAvant Global LLCBain Capital VenturesBessemer Venture Partners+33 more

Editas Medicineeditasmedicine.comin𝕏NASDAQ: EDITAug 2015

Editas Medicine develops gene editing medicines using CRISPR/Cas9 and CRISPR/Cas12a technology to treat serious diseases including blood disorders, cardiovascular conditions, and cancer.

BiotechDeep TechMedical DevicesCambridge, US

Feng Zhang(Founder)inGeorge Church(Scientific Founder, Professor of Genetics, Harvard University and MIT)inKeith Joung(Scientific Founder, Professor of Pathology, Harvard Medical School)inDavid Liu(Scientific Founder, Professor of Chemistry and Chemical Biology, Harvard University)inKatrine Bosley(Executive Officer, Director)inVic Myer(Executive Officer)in

Co-investorsEcoR1 CapitalSofinnova VenturesViking GlobalAtlas VentureDeerfield Management CompanyFlagship Ventures+2 more

EthosNASDAQ: LIFE

Ethos operates a digital platform that connects consumers, insurance agents, and carriers to facilitate the sale of life insurance and related products through direct consumer channels and a network of independent agencies.

Peter Colis(Chief Executive Officer and Chair of our Board of Directors)Lingke Wang(President and Director)Christopher Capozzi(Chief Financial Officer)Erin Lantz(Chief Revenue Officer)Vipul Sharma(Chief Technology Officer)

Co-investorsSequoia CapitalAccelGeneral CatalystHeroic VenturesSoftBank Group

Freenomefreenome.comin𝕏NASDAQ: FRNMOct 2015 · $65M

Freenome develops early-stage cancer detection technology using blood tests to identify cancer in its earliest, most treatable phases.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesLondon, US

Riley Ennis(Founder)inCharles Roberts(Founder)inGabriel Otte(Founder)inAdam Stone(Chief Executive Officer and Director)Michael Altman(Chief Business Officer and Director)Shmuel (Sam) M. Cohn(Chief Financial Officer)

Co-investorsRA CapitalAgent CapitalAME Cloud VenturesAndreessen HorowitzArtis VenturesAsset Management Company+15 more

GitLabgitlab.comin𝕏NASDAQ: GTLBSeries C · Aug 2016

GitLab is an intelligent orchestration platform for DevSecOps that enables teams and AI agents to collaborate on the full software development lifecycle, from planning through deployment, with integrated security and compliance capabilities.

AI & Machine LearningCybersecurityDeveloper ToolsEnterprise SoftwareSan Francisco, US

Sid Sijbrandij(CEO)inDmytro Zaporozhets(CTO)inDmitriy Zaporozhets(Founder)inPaul Machle(Executive Officer)inSytse Sijbrandij(Founder)

BoardBruce Armstrong(Director)in

Co-investorsAlkeon InnovationAugust CapitalBase PartnersBling CapitalCategory VenturesCoatue Management+36 more

Grailgrail.comin𝕏NASDAQ: GRAL

GRAIL develops the Galleri blood test for multi-cancer early detection using next-generation sequencing and machine learning to screen for multiple deadly cancer types before symptoms appear.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesMenlo Park, US

Jeffrey T. Huber(Director)Joshua Ofman, MD, MSHS(Chief Executive Officer)inAaron Freidin(Executive Officer)inRobert Ragusa(Executive Officer, Director)Jennifer Cook(Executive Officer, Director)inRichard Klausner(Director)

Co-investorsAmino CapitalARCH Venture PartnersBezos ExpeditionsBluebird VenturesDecheng CapitalDentsu Ventures+13 more

HubSpot, Inc.hubspot.comin𝕏NYSE: HUBS

HubSpot is a software platform that provides customer relationship management (CRM) and marketing automation tools for businesses.

AI & Machine LearningMarketing TechSaaSBoston, US

Brian Halligan(Co-founder)inDharmesh Shah(Co-founder)inYamini Rangan(Chief Executive Officer)inSarika GarginKate Bueker(Chief Financial Officer and Treasurer)Erika Fisher(Chief Legal Officer and Secretary)

Co-investorsArcher Capital GroupArcher Venture CapitalBantam GroupBoxGroupCross Creek AdvisorsCRV (Charles River Ventures)+13 more

Hyperfinehyperfine.ioin𝕏NASDAQ: HYPR

Hyperfine develops diagnostic imaging and data solutions for patient care.

AI & Machine LearningDeep TechHealthtechMedical Devices

Jonathan Rothberg(Founder)Maria Sainz(President, Chief Executive Officer and Director)Brett Hale(Chief Administrative Officer, Chief Financial Officer, Treasurer and Corporate Secretary)Thomas Teisseyre(Chief Operating Officer)Jonathan M. Rothberg(Founder)

Co-investorsAltium CapitalColle Capital PartnersDolby Family Ventures

Ideaya Biosciencesideayabio.comin𝕏NASDAQ: IDYA

IDEAYA is a precision medicine oncology company developing first-in-class targeted therapies and rational drug combinations for molecularly defined, hard-to-treat cancers.

BiotechDigital HealthHealthtechMedical DevicesSouth San Francisco, US

Paul Stone(Executive Officer)inYujiro S. Hata(President, Chief Executive Officer and Director)

BoardTimothy Shannon(Director)inJohn Diekman(Director)inTerry Rosen(Director)Jeffrey Stein(Director)

Co-investors5AM VenturesCanaan PartnersNextech InvestRoche Venture FundBiotechnology Value FundWuXi Healthcare Ventures

Invivydinvivyd.comin𝕏NASDAQ: IVVDApr 2021 · $336M

Invivyd is a biopharmaceutical company that develops antibody-based product candidates for the prevention and treatment of serious viral infectious diseases, combining viral surveillance and predictive modeling with antibody engineering.

BiotechHealthtechWaltham, US

Tillman U. Gerngross(Executive Officer, Director)Marc Elia(Founder)inLynn Connolly(Executive Officer)Eric Kimble(Executive Officer)inHalley Gilbert(Executive Officer)Rebecca Dabora(Executive Officer)in

Co-investorsBain Capital Life SciencesForesite CapitalMRL Ventures FundPremji InvestRA CapitalFidelity Investments+6 more

Lemonadelemonade.comin𝕏NYSE: LMNDDec 2016

Lemonade is a digital insurance provider offering homeowners, renters, car, pet, and term life insurance policies.

AI & Machine LearningConsumerInsurTechNew York, US

Daniel Schreiber(Founder)inShai Wininger(Founder)inMaya Prosor(Vice President, Distribution)inAdina Eckstein(Chief Operating Officer)inTim Bixby(Chief Financial Officer)inJohn Peters(Chief Insurance Officer)in

Co-investorsAlephAllianz XCanvas VenturesChampel CapitalDigital HorizonDigital Horizon VC+16 more

Maze Therapeuticsmazetx.comin𝕏NASDAQ: MAZEFeb 2019

Maze Therapeutics develops precision medicines for common diseases with high unmet need, using its Compass platform based on human genetics and variant functionalization.

AI & Machine LearningBiotechSouth San Francisco, US

Charles Homcy(Director)Jason Coloma(Chief Executive Officer)in

Co-investorsAndreessen HorowitzARCH Venture PartnersForesite CapitalFrazier Life SciencesHercules Capital, Inc.Alexandria+9 more

Monte Rosa Therapeuticsmonterosatx.comin𝕏NASDAQ: GLUESeries B · Sep 2020 · $96M

Monte Rosa develops molecular glue degrader (MGD) therapeutics using MGD chemistry, artificial intelligence, structural biology, and proteomics to target previously undruggable or inadequately drugged disease targets.

AI & Machine LearningBiotechDeep TechHealthtechBoston, US

Markus Warmuth(Chief Executive Officer)inSharon Townson(Ph.D., Chief Scientific Officer)inJohn Castle(Ph.D., Chief Data and Information Officer)inFilip Janku(M.D., Ph.D., Chief Medical Officer)inPhil Nickson(Ph.D., J.D., Chief Business and Legal Officer)inMagnus Walter(DPhil, Chief Technology Officer)in

Co-investorsAisling CapitalHBM PartnersNew Enterprise Associates (NEA)Versant VenturesAmzak HealthAvoro Capital Advisors+4 more

Neumora Therapeuticsneumoratx.comin𝕏NASDAQ: NMRASep 2020

Neumora is a clinical research company developing investigational medications, with a focus on conducting clinical trials to obtain regulatory approval and make treatments available to patients.

BiotechDeep TechDigital HealthMedical DevicesWatertown, US

Paul L. Berns(Chairman and Chief Executive Officer)Joshua Pinto(Executive Officer)Tamara Tompkins(Executive Officer)inKari Stefansson(Director)Maykin Ho(Director)Alaa Halawa(Director)

Co-investorsARCH Venture PartnersCatalio Capital Management, LPF-Prime CapitalK2 HealthVenturesMercury FundPremier Partners+12 more

Neutron HoldingsNASDAQ: LIMEMay 2020

Neutron Holdings, doing business as Lime, operates shared electric scooters, bikes and mopeds in cities worldwide.

San Mateo, US

Weiyao Sun(Executive Officer, Director, Promoter)Zhoujia Bao(Executive Officer, Director, Promoter)

BoardJeff Jordan(Director)in

Co-investors1435 CapitalManhattan Venture PartnersAndreessen HorowitzBain Capital VenturesSapphire VenturesUber

Nextdoornextdoor.comin𝕏NYSE: NXDROct 2013

Neighborhood social network; IPO 2021

AdTechSan Francisco, US

Nirav Tolia(Founder)inSarah Leary(Founder)inPrakash Janakiraman(Founder)inDavid Wiesen(Founder)inIndrajit Ponnambalam(Chief Financial Officer)Sarah Friar(Former CEO, President & Chairperson)in

Co-investorsAxel Springer Digital VenturesBond Capital ManagementCoatue ManagementComcast VenturesCota CapitalDag Ventures+25 more

Opendooropendoor.comin𝕏NASDAQ: OPEN

Opendoor offers instant cash offers for residential properties through real estate agents, allowing sellers to choose between a fast sale or list the home later.

B2B MarketplacesE-commerceMarketplacesPropTechPhoenix, US

Eric Wu(Founder)inJD Ross(Founder)Keith Rabois(Founder)inKaz Nejatian(Chief Executive Officer)inIan Wong(Founder)

Co-investorsA*Access Technology VenturesAirTree VenturesAndreessen HorowitzBlue LionBlue Lion Global+42 more

Oscar Healthhioscar.com𝕏NYSE: OSCR

Oscar Health is a healthcare technology company that builds and operates a health insurance platform, offering individual, small group, and Medicare Advantage plans to members across the United States.

Digital HealthHealthtechInsurTechNew York, US

Mario Schlosser(Founder)inJoshua Kushner(Founder)Mark T. Bertolini(Chief Executive Officer)inJosh Kushner(Founder)Kevin Nazemi(Founder)

Co-investors8VCA-Rod CorpBoxGroupBreyer CapitalCapitalGCoatue Management+22 more

Parabilis Medicinesparabilismed.cominNASDAQ: PBLSSeries B · May 2018 · $66M

Helicons develops a peptide-based therapeutic platform designed to target intracellular proteins previously considered undruggable by combining the specificity of antibodies with the cell-penetrating properties of small molecules.

AI & Machine LearningBiotechDeep TechMedical Devices

Mathai Mammen(CEO, President and Chairman)in

Co-investorsARCH Venture PartnersCatalio Capital Management, LPDeerfield Management CompanyForesite CapitalFrazier Life SciencesGeneral Catalyst+9 more

Rani Therapeuticsranitherapeutics.cominNASDAQ: RANISeries B · Jul 2013 · $9M

Rani Therapeutics develops oral drug delivery technology using robotic capsules to replace injectable biotherapeutics, addressing the challenge of delivering biologics through the gastrointestinal tract without needles.

BiotechDigital HealthHealthtechMedical DevicesSan Jose, US

Mir Hashim(Executive Officer, Director)inTalat Imran(Chief Executive Officer)in

BoardMir Imran(Founder)Andrew Farquharson(Director)in

Co-investorsInCube VenturesRA CapitalVHM

Revolution Medicinesrevmed.cominNASDAQ: RVMD

Revolution Medicines is a biopharmaceutical company focused on discovering and developing medicines using its proprietary Tri-Complex Platform and RAS(ON) Biology research approach.

BiotechHealthtechMedical DevicesRedwood City, US

Margaret Horn(Executive Officer)Mark A. Goldsmith(Executive Officer, Director)inJack Anders(Chief Financial Officer)Stephen M. Kelsey(President, Research and Development)Alan Sandler(Chief Development Officer)inAnthony Mancini(Chief Global Commercialization Officer)

Co-investorsBain Capital Life SciencesForesite CapitalGen CapitalIllinois VenturesNextech InvestThe Column Group+2 more

Robinhoodrobinhood.comin𝕏NASDAQ: HOODAug 2019

Robinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets.

FintechMenlo Park, US

Vlad Tenev(Founder)inBaiju Bhatt(Founder)inJason Warnick(Chief Financial Officer)inGretchen Howard(Executive Officer)inVladimir Tenev(Founder)

BoardScott Sandell(Director)in

Co-investors1/1 CapitalACME CapitalAlgerAliya Capital PartnersAmplo VenturesAndreessen Horowitz+66 more

Schrodingerschrodinger.cominNASDAQ: SDGRJun 2015

Schrödinger develops a physics-based computational platform for discovering and optimizing molecules, used to accelerate drug discovery and materials design.

AI & Machine LearningBiotechDeep TechNew MaterialsNew York, US

Richard A. Friesner(Founder)Ramy Farid(Executive Officer, Director)inRamy Farid, Ph.D.(President and CEO, Board Member)Murco Ringnalda(Executive Officer)William Andrew Goddard III(Founder)William Goddard(Founder)

Co-investorsQiming Venture PartnersBill & Melinda Gates Foundation TrustSixty Degree Capital

Spero Therapeuticssperotherapeutics.cominNASDAQ: SPRO

Spero Therapeutics is a clinical-stage biopharmaceutical company developing medicines for immune-mediated diseases, led by SP001, a third-generation anti-CD40L antibody targeting IgG4-related disease.

BiotechCambridge, US

Ankit Mahadevia(Executive Officer, Director)inStephen Garbacz(Executive Officer)inEsther Rajavelu(Director, President, Chief Executive Officer, Chief Financial Officer, Chief Business Officer and Treasurer)in

BoardJean-Francois Formela(Director)inReza Halse(Director)Casper Breum(Director)

Co-investorsHEALTHCARE ROYALTY PARTNERSMRL Ventures FundOUP (Osage University Partners)RA CapitalAlphabetAtlas Venture+1 more

Taysha Gene Therapiestayshagtx.comin𝕏NASDAQ: TSHA

Taysha Gene Therapies develops and commercializes gene therapies for monogenic diseases of the central nervous system, serving patients with rare and larger CNS conditions.

BiotechDeep TechDigital HealthHealthtechMedical DevicesTexas, US

R.A. Session II(Executive Officer, Director)inSean P. Nolan(Chief Executive Officer and Board Chairman)in

BoardPaul B. Manning(Director)in

Co-investorsBairdGoldman SachsJefferiesPBM Capital

Tenaya Therapeuticstenayatherapeutics.comin𝕏NASDAQ: TNYA

Tenaya Therapeutics is a biotechnology company focused on discovering and developing therapies for heart disease.

BiotechHealthtechSouth San Francisco, US

Deepak Srivastava, M.D.(Scientific Founder)inEric Olson, Ph.D.(Scientific Founder)Bruce R. Conklin, M.D.(Scientific Founder)inSheng Ding, Ph.D.(Scientific Founder)Saptarsi Haldar, M.D.(Scientific Founder)inEric Hyllengren(Chief Financial Officer)in

Co-investorsRA CapitalThe Column GroupvenBio Partners

Toasttoasttab.cominNYSE: TOST

Toast provides a restaurant management platform combining point-of-sale hardware (Flex POS, Toast Go 3 handheld) with software tools for online ordering, payroll, and other operations.

FintechFoodTechRetail TechSaaSBoston, US

Stephen Fredette(Executive Officer, Director, Promoter)Jonathan Grimm(Founder)inAman Narang(Founder)inChristopher Comparato(Executive Officer, Director)Steve Fredette(Founder)

BoardSteve Papa(Director, Promoter)

Co-investorsBessemer Venture PartnersBlue Owl CapitalConnetic VenturesEvolution VC PartnersF-Prime CapitalFIRSTFLOOR CAPITAL+15 more

Uberuber.comin𝕏NYSE: UBER

Uber operates a multi-sided platform providing ride-sharing, food delivery, freight logistics, and business fleet management services across various global markets.

Logistics & Supply ChainMarketplacesMobility & TransportationSan Francisco, US

Travis Kalanick(Founder)Garrett Camp(Founder)inGautam Gupta(Executive Officer)inJeffrey Holden(Executive Officer)David Plouffe(Executive Officer)inEmil Michael(Executive Officer)in

Co-investors137 Ventures3Spoke Capital408 VenturesA*ACME CapitalAcross Capital Partners+91 more

Upstartupstart.comNASDAQ: UPST

Upstart is an AI lending marketplace that partners with banks and credit unions to underwrite personal, auto and small-dollar loans on more than traditional credit scores; it went public on the Nasdaq in December 2020.

Palo Alto, US

Paul Gu(Founder)Dave Girouard(Founder)inAlison Nicoll(Executive Officer)inRyan Randall(Executive Officer)Sanjay Datta(CFO of Administrator, Upstart Network, Inc.)inAnna Counselman(Founder)

Co-investorsAlumni VenturesBallistic VenturesBasecamp FundCollaborative FundCorrelation VenturesEudemian Ventures+12 more

Virvir.bioin𝕏NASDAQ: VIR

Vir Biotechnology develops treatments for infectious diseases and oncology, leveraging immunology-focused scientific capabilities.

AI & Machine LearningBiotechDigital HealthMedical DevicesSan Francisco, US

Marianne De Backer(CEO)inHerbert Virgin(Executive Officer)Howard Horn(Executive Officer)inAlex Bangs(Executive Officer)inMarianne De Backer, M.Sc., Ph.D., MBA(President, Chief Executive Officer and Director)

BoardGeorge Scangos(Executive Officer, Director)

Co-investorsAlta PartnersARCH Venture PartnersSoftBank Vision Fund8VCALTITUDE LIFE SCIENCE VENTURESDCVC (Data Collective)+1 more

dope.securitydope.securityin𝕏Mar 2023 · $16M✓ verified

A cybersecurity company focused on improving user experience and product quality, positioning itself against vendors that prioritize marketing over practical solutions.

AI & Machine LearningCybersecurityEnterprise SoftwareSaaSMountain View, US

Kunal Agarwal(Founder)in

BoardEd Sim(Director)inSteve Schoenfeld(Director)

Board seatSangeen Zeb· per SEC Form D

Co-investorsboldstart venturesPreface Ventures

Tessltessl.ioin𝕏Seed · Nov 2024 · $125M✓ verified

Tessl builds an AI Native software development platform with tools for developers building with AI agents, centered on preserving intent and context rather than code.

AI & Machine LearningDeveloper ToolsEnterprise SoftwareSaaSLondon

Guy Podjarny(Founder)inKenneth MacAskill(Director)

BoardEdward Sim(Director)Carlos Gonzalez-Cadenas(Director)in

Board seatTom Hulme· per SEC Form D

Co-investorsAccelIndex Venturesboldstart venturesDarkmode Venturesfirstminute capitalLocalGlobe

Blockaidblockaid.ioin𝕏Feb 2025 · $50M✓ verified

Blockaid is a real-time onchain security platform for web3 builders, used to observe onchain assets, detect anomalies, and mitigate risk across blockchains, wallets, and connected web properties.

AI & Machine LearningCrypto & Web3CybersecuritySaaSNew York, US

Ido Ben-Natan(Founder)inRaz Niv(Founder)inRoni Sidi(General Counsel)in

BoardJason Risch(Board Observer / Director (Greylock investor representative))in

Co-investorsCyberstartsGreylock PartnersRibbit CapitalSequoia CapitalJibe VenturesReverie+2 more

Cerevancecerevance.comin𝕏Series B · May 2026 · $20M✓ verified

Cerevance develops precision novel therapeutics for central nervous system disorders, particularly neurodegenerative diseases, using its proprietary NETSseq platform and machine learning to identify targets from an extensive collection of human brain tissue samples.

AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesBoston, US

Craig Thompson(Chief Executive Officer)inSagar Vaidya(Chief Medical Officer)inCarrie Ann Cook(Chief Business Officer)Mark Carlton(Chief Scientific Officer)inOttavio V. Vitolo(Chief Medical Officer)in

Co-investorsDementia Discovery FundForesite CapitalSV Life SciencesDementia DiscoveryDolby Family VenturesLightstone Ventures+4 more

Clever Care Health Planclevercarehealthplan.cominSeries C · Mar 2023 · $42M✓ verified

Clever Care is a culturally and linguistically sensitive Medicare Advantage health plan serving Southern California that integrates Eastern and Western medicine approaches.

HealthtechInsurTechSouthern California, US

Myong Sun Lee(Executive Officer, Director)Hiep Dinh Pham(Executive Officer, Director)Dave Firdaus(Executive Officer, Director)

Co-investorsNorwest Venture PartnersGlobal Founders CapitalNovo HoldingsAV8 VenturesFigure 8 InvestmentsPruVen Capital Partners+1 more

Climate Xclimate-x.comin𝕏Jun 2024✓ verified

Climate X offers the Infrastructure Climate Risk Screener, a self-serve tool that assesses physical climate risk across spatially complex infrastructure assets such as solar farms, wind farms, transmission lines, pipelines, water utilities, roads, and rail by screening them against 11 hazards.

AI & Machine LearningClimate TechFintechSaaSLondon, GB

Lukky A.(Founder)inKamil Kluza(Founder)in

Co-investorsBlue Wire CapitalCommerzVenturesnoaWestern Technology InvestmentBlue ImpactDeloitte Ventures+10 more

Comanche Biopharmacomanchebiopharma.cominSeries A · Jan 2024 · $75M✓ verified

Comanche Biopharma is a biopharmaceutical company developing an investigational siRNA medicine (CBP-4888) targeting a root cause of preterm preeclampsia in pregnant women.

BiotechFemTechHealthtechConcord, US

Mike Young(Founder)inT Scott Johnson(Founder)inPaul Antinori(Executive Officer)Allison August(Executive Officer)inThomas Scott Johnson(Executive Officer, Director)

BoardBrendan Bulik-Sullivan(Director)in

Co-investorsAtlas VentureBroadview VenturesF-Prime CapitalLilly Asia VenturesNew Enterprise Associates (NEA)

DualEntrydualentry.comin𝕏Series A · Oct 2025 · $90M✓ verified

DualEntry is an AI-native enterprise resource planning (ERP) platform designed to replace legacy accounting systems for mid-market to enterprise businesses.

AI & Machine LearningEnterprise SoftwareFintechSaaSNew York, US

Santiago Nestares(Founder)inBenedict Dohmen(Founder)inSantiago Nestares Benedict Dohmen(Founder)

Co-investorsContraryKhosla VenturesLightspeed Venture PartnersCarya Venture PartnersLightspeed India PartnersLudlow Ventures+10 more

Fathomfathomhealth.comin𝕏May 2019✓ verified

Fathom structures and organizes healthcare data to address inefficiencies in the healthcare system.

AI & Machine LearningData & InfrastructureDigital HealthHealthtechOakland, US

Chris(CTO)Enoch(COO)Rishi Reddy(Director)Andrew Lockhart(Founder)Christopher Bockman(Founder)Richard White(Founder)in

Co-investorsLightspeed Venture PartnersFounders FundAlkeon InnovationGreat Oaks Venture CapitalLifeforce CapitalMBX Capital+6 more

Flapping Airplanesflappingairplanes.com𝕏Jan 2026✓ verified

Flapping Airplanes is a foundational AI research lab working on the data efficiency problem, aiming to build models that reach human-level reasoning without training on vast amounts of data.

AI & Machine LearningDeep TechSan Francisco, US

ASHER SPECTOR(Executive Officer, Director)inBENJAMIN SPECTOR(Executive Officer, Director)Aidan Smith(Founder)inAsher Spector(Founder)Ben Spector(Founder)

Co-investorsIndex VenturesSequoia CapitalArgoConvictionFundomoMenlo Ventures+2 more

Genie AIgenieai.coin𝕏Series A · Oct 2024 · $17.8M✓ verified

Genie AI applies artificial intelligence to legal work, focusing on how businesses draft and transact legal contracts.

AI & Machine LearningEnterprise SoftwareLegalTechSaaSLondon, GB

Rafie Faruq(Founder)inNitish Mutha(Founder)in

Co-investorsKhosla VenturesEntrepreneur First

Guildguild.aiin𝕏✓ verified

Guild provides an observability and control runtime for AI agents, capturing full session traces of every model call, tool invocation, input, output, and decision at runtime.

AI & Machine LearningData & InfrastructureDeveloper ToolsEnterprise Software

James Everingham(Founder)in

Co-investorsAcrew CapitalNFX515 VenturesScribble VenturesWebb Investment Network

humans&humansand.ai𝕏Feb 2024 · $480M✓ verified

humans& is a frontier AI lab focused on building human-centric AI systems that prioritize people and their relationships, emphasizing innovations in reinforcement learning, memory, and user understanding to create AI that strengthens organizations and communities.

AI & Machine LearningEnterprise SoftwareSaaSEl Segundo, US

Eric Zelikman(Founder)inNoah Goodman(Founder)inGeorges Harik(Founder)Alaarif Nooruldeen(Executive Officer, Director)Andi Peng(Founder)Ray Ramadorai(Founder)

Co-investorsS32SV AngelNVIDIAA.Capital VenturesAlumni VenturesBloomberg Beta+19 more

Isomorphic Labsisomorphiclabs.comin𝕏Series A · Mar 2025 · $600M✓ verified

Isomorphic Labs applies artificial intelligence to drug discovery, working to develop treatments for serious diseases.

AI & Machine LearningBiotechDigital HealthHealthtech

Demis Hassabis(Founder)in

Co-investorsCapitalGAlphabetMGXTemasekThrive CapitalCathay Innovation+3 more

Leyden Labsleydenlabs.comin✓ verified

Leyden Labs develops nasal sprays containing antibodies that target respiratory viruses such as influenza and COVID at the nasal mucosa to prevent initial infection and transmission.

BiotechDeep TechHealthtechLeiden, NL

Koenraad Wiedhaup(Founder & Chief Executive Officer)inRonald Brus(Founder & Chief Growth Officer)inJaap Goudsmit(Founding Scientist and Senior Advisor)inDinko Valerio(Founder and Chair of the Supervisory Board)inJintanat Ananworanich(Chief Medical Officer)inClarissa Koch(Chief Scientific Officer)in

Co-investorsClavystBioF-Prime CapitalBluebird VenturesByers CapitalCasdin CapitalEuropean Innovation Council Fund+7 more

Mechanical Orchardmechanicalorchard.comin𝕏Aug 2024 · $50M✓ verified

Mechanical Orchard modernizes legacy enterprise systems, including mainframes, by using an AI-driven, component-by-component approach that rebuilds and tests each part in a secure cloud environment before deployment.

AI & Machine LearningCloud ComputingDeveloper ToolsEnterprise SoftwareSan Francisco, US

Rob Mee(Founder)inEdward Hieatt(COO)inDan Podsedly(Founder)Matthew Work(Founder)

Co-investorsFin CapitalBloomberg BetaEmergence Capital PartnersSpider CapitalSummit Peak InvestmentsWebb Investment Network+3 more

Mestagmestagtherapeutics.comin𝕏Mar 2026 · $40M✓ verified

Mestag is an immunology company developing first-in-class treatments for cancer and inflammatory diseases by leveraging novel understanding of fibroblast biology and tertiary lymphoid structures.

AI & Machine LearningBiotechDigital HealthHealthtechLondon, GB

Michael B. Brenner(Founder)Chris Buckley(Founder)Mark Coles(Founder)inSoumya Raychaudhuri(Founder)David A. Tuveson(Founder)Lindsey Rolfe(Chief Medical Officer)in

Co-investorsSV Health InvestorsForbionJohnson & Johnson Innovation – JJDCNorthpond VenturesJJDC

Monzomonzo.comin𝕏Mar 2024✓ verified

Monzo is a UK digital bank offering personal and joint current accounts managed through a mobile banking app, with features including balance checking, UK and international transfers, cheque deposits, and arranged overdrafts.

ConsumerFintechLondon, GB

Tom Blomfield(Founder)inJonas Templestein(Co-Founder & CTO)inJason Bates(Founder)inPaul Rippon(Founder)inGary Dolman(Founder)inSusan Adams(Executive Officer)in

Co-investorsCapitalGHedosophiaPassion CapitalTencent HoldingsAccelAlanda Capital Holding Limited+19 more

Neo4jneo4j.comin𝕏Sep 2020✓ verified

Neo4j develops a graph database and graph data platform used to build applications that leverage connected data, with products including AuraDB, Graph Data Science, and vector search for GraphRAG and GenAI use cases.

AI & Machine LearningData & InfrastructureEnterprise SoftwareSan Mateo, US

Emil Eifrem(Founder)inMichael Asher(Executive Officer)Johan Svensson(Founder)Peter Neubauer(Founder)

BoardLars Nordwall(Executive Officer)inMichael Treskow(Director)

Co-investorsInovia CapitalCreandumEurazeoAlanda Capital Holding LimitedDawn CapitalF-Prime Capital+7 more

nPlannplan.ioin𝕏Jan 2026✓ verified

nPlan builds AI trained on a dataset of over 750,000 historical construction project schedules to forecast schedule risk, generate and check schedules, and support project controls for capital projects.

AI & Machine LearningConstruction TechSaaSLondon, GB

Dev Amratia(CEO & Co-Founder)inAlan Mosca(CTO & Co-Founder)inJade Bouhmouch(Head of Operations)in

Co-investorsEntrepreneur FirstFounder CollectiveLocalGlobePentech VenturesSuffolk TechnologiesAlphabet+2 more

Omassomass.comin𝕏Series B · Apr 2022 · $95M✓ verified

OMass is a biotech company that originated as a spinout from Oxford University, developing specialized treatments for patient populations with high unmet medical needs.

BiotechDeep TechDigital HealthHealthtechMedical DevicesOxford, GB

Professor Dame Carol Robinson(Founder and Chair of Scientific Advisory Board)Idlir Liko(Founder)inJonathan Hopper(Vice President, Platforms and Founder)inHsin Yung (Jason) Yen(Founder)inRos Deeganin

Co-investorsOxford Science EnterprisesSanofi VenturesNorthpond Ventures

Paradigm Healthparadigmhealth.aiinDec 2025 · $78M✓ verified

Paradigm Health provides technology and services that integrate with healthcare provider organizations to improve the clinical trial process.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesSaaSColumbus, US

Kent Thoelke(Founder)inJonathan Hirsch(Chief Strategy and Growth Officer)Jay Trepanier(Chief Financial Officer)inElijah Meerson(Chief Technology Officer)inMichelle Lee(Chief Operating Officer)in

Co-investorsARCH Venture PartnersGeneral CatalystLux CapitalF-Prime CapitalJobsOhio VenturesMagnetic Ventures+2 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Decibel Therapeutics, Inc.JenZMist Systems, Inc.Push Security, Inc.TwylaAdapterAdelphic MobileAgainAltSpaceVRAppurifyARMO BioSciencesArsanisAspireAutolusBeacon BiosignalsBitterroot BioBlackThorn TherapeuticsBounti Labs

Browse all 944 investments with full details →

▶744 more tracked companies

BrowserlingBuenaBuenaBufferBoxBugsnagBuoyantBuoyantBustleButtercoinCacheflowCalaCala HealthCambium CapitalCamblyCambridge EpigenetixCameoCaptureCarawayCarawayCarbonCardurionCardurion PharmaceuticalsCarebridgeCareer KarmaCarmeraCarnival MobileCarrick TherapeuticsCatenaCelsius TherapeuticsCensysCensys TechnologiesCheckmateCheckrCheckrChroma MedicineChronosphereCircleUpCircuitHubClarifaiClassPassClear LabsClearStory DataCleverCleverCleverClever CareCliQrClouderaClover HealthClusterClutterCmdCoaster CyclesCockroach LabsCognosysCohereCohesityCollaborateCollective HealthComfyUICompliance.aiComplyanceComstructConfideContextContinua AIContralineCool Planet TechnologiesCopperCopperCordCorduroCortex AICosmosCosmos Entity, Inc.CounselCounsel HealthCourierCozy FinanceCreativeLIVECrews by CoreCriblCryptoKittiesCTRL LabsCUR8Curie BioCurrency CloudCustomerCustomer.ioCustomMadeCybergrxCymbalCymbalDapper LabsDasientDataFoxDatanyzeDaydreamdbt LabsDeepsetDelightedDelphia TherapeuticsDelve BioDenver TechnologiesDesktop MetalDesmosDetermined AIDevoted HealthDialpadDigitDigit TechnologiesDigitsDistanceDistance TechnologiesDiverge HealthDivideDoctor on DemandDopplerDriverDriverDuo SecurityDyno TherapeuticsEasyPostEgnyteEmergent VREmilEmissaryEncoded TherapeuticsEncodiaEnduroSatEnglish CentralEnvelop VREnviseEpi BiologicsEQRxEthosEveloEvelo BiosciencesEveryONE MedicinesEvox TherapeuticsExperienceExperienceF5FabricFabric CommerceFarmers Business NetworkFarmwiseFarmwise LabsFaunaFinFireflyFireflyfirsthandFirsthandFitStarFlatironFlatiron HealthFlexion RoboticsFlexportFlickFlickFlickFlock FreightFlourishFlutterFlowFLX BioForty Seven IncFoundFoundation MedicineFramedFramed DataFreenome HoldingsFreshplumFytoFytoGametimeGaston LabsGate BioGenesisGenesis GlobalGenesis Molecular AIGenieGenieGenieGenome MedicalGenomics Medicine IrelandGeometricGiphyGlass ImagingGoCardlessGood EggsGoogleGowallaGraftGranata BioGranular.aiGravityGravity SketchGravityclimateGritstone bioGritstone OncologyGroundswellGuide TherapeuticsGuidelight HealthGustoGyftHAGSHanoverparkHappiest BabyHarnessHarveyHeadwayHeartThisHeavyHebbiaHeliumHelixHelixHelloSignHigh FidelityHighfiveHipsterHome From CollegeHomeAwayHomeAway, Inc.HomeboundHomejoyHomelightHOVERHustleSasaHyperfine ResearchIconOVir BioImagenImagen TechnologiesImpossible FoodsIncluded HealthInertiaInfinitusInsitroInstaworkIntercomInvetxIonic SecurityIonQ (IONQ)Iora HealthiPierianITERATIVEIterative HealthItsaCheckmateJauntJetJet.comJetifyJetpackJoyTunesJuiceroJumpCamKabamKamcordKarmaKarmaKarmaKenshoKickkindbodyKindredKindred VoiceKinetic AppsKitchen UnitedKnapsackKobaltKobaltmusicKraftfulKronos BioLaBarge WeinsteinLaceworkLakestarLandisLapseLatticeLaunchkitLaurel AILawhiveLawPivotLe ToteLedger XLedgerXLendUpLevelUpLightLightmatter®Lightspeed Venture PartnersLimeLolaLolaLoomLoomLoreLotusflareLoveveryLoveverybabyLuminateLuminateLuminate WirelessLuna ParkLuvocracyLuxeLuxury Vacation RentalsLytical VenturesMachinifyMacroscopeMagenta TherapeuticsMakaniMakeSpaceMakewonderManaged by QMandiantMatterMedallionMediumMeltanoMerida BiosciencesMerlin LabsMessageMeMetabiotaMetaviewMetseraMidi HealthMighty AIMighty AIMilk VideoMillMimicMindMeldMindSumoMirrorTabMirvieMisoMisoMitroMobileDayModeModeModern AgeModsy_ModularMohawkMoknMoonHubMoonwalk BiosciencesMotherMotherMother GamesMotiveMotiveMove LootmParticleMSTMultiverseMultiversemyLaurelMypocketcfoMySQLN3tworkNamo MediaNanitNavaNava BenefitsNava TherapeuticsNavier AInChroma BioNebexNectarNectarNectarNectar SocialNeotaxNerd ApplyNestNestNeuralink-LogoArtboard-1nextbitNextSenseNgmocoNimbleNimbleNimbusNimbusNimbusNimbusNimbusNimbus TherapeuticsNoRedInkNothingNothing TechNovaNova LabsNYMNym HealthOasis HealthOasis Health PartnersOblenio BioOboeObsidianObsidian SecurityObsidian TherapeuticsOdysseyOdysseyOdysseyOmeatOmniOmniOmniOmni AnalyticsOmni Analytics, Inc.OnDeck AIOndeck CapitalOne MedicalOnsite ProOpenbayOpenEvidenceOptimizelyOptiwattOrange ChefOrationOrbital InsightOrbitHCIOrgOrgOsmoOsmo LabsOula HealthOutdoor VoicesOutlierOutlierOutlier BetOutRival, Inc.Overture GamesOverture LifeOverviewOwkinOxford Science EnterprisesPackagdPACT PharmaPagerPangeaPanoramaPanorama EducationParadigm HealthParsableParsePartifulPartnersPatina HealthPayRangePecan AIPeerspacePeiPensandoPeopleone HealthPerceive BioPerceive BiotherapeuticsPerceive PharmaPercolataPeriscopePeriscope DataPhoebePhoebePhysnaPindropPioneering precision epigenetic medicinesPipekitPixiePixie LabsPlaidPlanGridPlexxiPocketPodiumPostHogPoyntPredilyticsPretzel TherapeuticsProduct HuntPrudentia SciencesPullRequestPuppetPushsecurityPYA AnalyticsQQ1Q2Qiming USQuadraticQualtricsQuartetQuettraRampRAPT TherapeuticsReactionReaction CommerceRead It LaterReady RespondersRecorded FutureRecursive Super IntelligenceRedpandaRelay TherapeuticsRelayRidesRepublic ProjectReserveResilienceResilienceResistant AIResolution GamesRetailMeNotRewireRhyGaze AGRicursive IntelligenceRightHandRillaRipcordRIPPL CareRipple FoodsRipple LabsRiseRISERoboflowRocanaRocheRockbotRocket FuelRocket LawyerRocketripRodin TherapeuticsRogerROGERRome AIROME TherapeuticsRomotiveroxRoxRumrSana BiotechnologySanasSardineSaviokeScale AIScalusScalyrScanScanditSchematic LabsSchrödingerScience 37Scope3Scout RFPSecret EscapesSegmentSeismic TherapeuticSenseSensorumSesameSesameShape SecuritySideQuestSierraSiftSiftSiftSiftSignosSignpostSilver Spring NetworksSilver Springs NetworkSimperiumSimplySingleStoreSkycatchSkyport SystemsSlackSlidePaySmartererSmolSnorkel AISnowballSnykSoldSolve HealthcareSolveAISonoma BiotherapeuticsSoylentSoylentSpace MonkeySpeakeasySpeakeasySpeakeasySpeedy LabsSpeedyBrandSpinLaunch Inc.SpringSpringSprinter HealthSpruce FinanceSpruce HealthSQZ BiotechSQZ BiotechnologiesStackblitzStackOneStampedStatusProStipple BioStockXStorjStrella BiotechnologyStripeStrongDMStudent ExperienceSubtextSubtextSummer HealthsuperglueSweetLabsSwellSWELLswing educationSynackSynapticureSync Labssync.SynthesiaSyremis TherapeuticsTALATamrTaylorTeemtendTendTendTennrTenorTenSixteen BioTenxer LabsThatchThatch HealthThe Climate CorporationThe Interaction Company of CaliforniaThe Pill ClubThe Players TribuneThe SkimmTheraThinking MachinesThinking Machines LabThinkNearThousandEyesTMRW Life SciencesTrace NeuroscienceTracelyticsTradaTranscripticTranslucent AITransphormTravelJoyTrue VenturesTrueLensTScan TherapeuticsTuneinTuroTypefaceUbersenseUdacityUjetUnbabelUniverseUpthereUrban EnginesUrban MachineUrbanmachineUrsa ComputingURXVaretoVartanaVayableVeemVentus AIVentus TherapeuticsVeoVeoVeo RoboticsVera TherapeuticsVerana HealthVercelVersant VenturesVerseVerse EnterprisesVerveVezaVicinitas TherapeuticsVIDAVIDA & Co.ViglinkVillageSQLVitara BiomedicalViz AiVocodeVoiceaVoidVoltageVoltron DataVonVungleWalker and CompanyWaltz HealthWanderWantworthyWarpWarpWatch ClubWatchClub TVWaymoWealthWeaveworksWinguWitness aiWittlebeeWonderWonder WorkshopWonderbly exitedWonderhillXilis, Inc.Yellowbrick DataYeswareYieldifyYieldmoYuga LabsZappRxZencoderZencoderZenPayrollZephyr HealthZestZeusZiplineZiplineZiplineZipline

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

Exits · 152

40 IPOs · 112 acquisitions · showing 49

Prime MedicineNASDAQ: PRME1Life HealthcareNasdaq (historical; delisted after acquisition): ONEMDenali TherapeuticsNASDAQ: DNLIA Place for MomNASDAQ: GDRXAlectorNASDAQ: ALECBarinthusbioNASDAQ: BRNSBeam TherapeuticsNASDAQ: BEAMCompass TherapeuticsNASDAQ: CMPXDocuSignNASDAQ: DOCUEditas MedicineNASDAQ: EDITEthosNASDAQ: LIFEFreenomeNASDAQ: FRNMGitLabNASDAQ: GTLBGrailNASDAQ: GRALHubSpot, Inc.NYSE: HUBSHyperfineNASDAQ: HYPRIdeaya BiosciencesNASDAQ: IDYAInvivydNASDAQ: IVVDLemonadeNYSE: LMNDMaze TherapeuticsNASDAQ: MAZEMonte Rosa TherapeuticsNASDAQ: GLUENeumora TherapeuticsNASDAQ: NMRANeutron HoldingsNASDAQ: LIMENextdoorNYSE: NXDROpendoorNASDAQ: OPENOscar HealthNYSE: OSCRParabilis MedicinesNASDAQ: PBLSRani TherapeuticsNASDAQ: RANIRevolution MedicinesNASDAQ: RVMDRobinhoodNASDAQ: HOODSchrodingerNASDAQ: SDGRSpero TherapeuticsNASDAQ: SPROTaysha Gene TherapiesNASDAQ: TSHATenaya TherapeuticsNASDAQ: TNYAToastNYSE: TOSTUberNYSE: UBERUpstartNASDAQ: UPSTVirNASDAQ: VIRCoreOSacq. by Red HatMist Systems, Inc.acq. by Juniper NetworksAbacusacq. by CertifyAhanaacq. by IBMAlfieacq. by KnownwellAnchor FMacq. by SpotifyApptimizeacq. by AirshipAppurifyacq. by GoogleAspireacq. by AnthemAspire Healthacq. by CareMore Health (Anthem)Astridacq. by Yahoo

Portfolio news

latest coverage across their companies

IPO stake values · per SEC filings · 6

Value of this firm's stake in each portfolio company at its IPO price, from the prospectus principal-stockholder table.

CompanyOwnedIPO priceAt IPOStake value
Prime Medicine13.0%$17.00Oct 2022$212.2M
Parabilis Medicines4.1%$20.00Jun 2026$96.7M
Invivyd5.2%$17.00Aug 2021$96.6M
Ethos12.4%$19.00Jan 2026$71.6M
Maze Therapeutics5.5%$16.00Jan 2025$38.6M
Barinthusbio5.0%$17.00Apr 2021$29M

Source: SEC S-1 / 424B prospectus filings. Stake value = shares beneficially owned × the initial public offering price, as disclosed — a market value at IPO, not a return multiple (the firm's original cost is not disclosed).

Frequently asked questions

How many investments has GV (Google Ventures) made?
GV (Google Ventures) has 944 tracked investments, 152 of which have exited, including 124 dated in the last 24 months.
What stage does GV (Google Ventures) invest at?
GV (Google Ventures) invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
What is GV (Google Ventures)'s typical check size?
GV (Google Ventures) typically writes checks of $250K – $50M.
What sectors does GV (Google Ventures) focus on?
GV (Google Ventures) focuses on AI & Machine Learning, Biotech, Cloud Computing, Consumer, Cybersecurity, Data & Infrastructure, Deep Tech, Developer Tools, Digital Health, Enterprise Software, Fintech, Hardware, Healthtech, Longevity, Medical Devices, Mental Health, Robotics, SaaS, Sector Agnostic, Semiconductors.
Where is GV (Google Ventures) located?
GV (Google Ventures) is headquartered in Mountain View, US.
Does GV (Google Ventures) lead rounds?
Yes, GV (Google Ventures) leads investment rounds.
Who does GV (Google Ventures) co-invest with?
GV (Google Ventures) most often shares deals with Y Combinator, Andreessen Horowitz, Kleiner Perkins, among 1,494 tracked co-investors.

Media · Podcasts & interviews

featuring the team

Images

GV (Google Ventures) photoGV (Google Ventures) photoGV (Google Ventures) photoGV (Google Ventures) photoGV (Google Ventures) photoGV (Google Ventures) photo

Co-investors · 556

Andreessen Horowitz

Andreessen Horowitz (a16z) is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz, known for pioneering the platform model with a large team of operators supporting founders across stages.

$500K – $50M
▶544 more co-investors

Tiger Global ManagementFelicis VenturesMenlo VenturesIndex VenturesRedpoint VenturesGreylock PartnersIVP (Institutional Venture Partners)SoftBank Vision FundInsight PartnersFirst Round CapitalCoatue ManagementF-Prime CapitalBessemer Venture PartnersDCVC (Data Collective)Lux CapitalTechstarsInitialized CapitalSpark CapitalCasdin CapitalNorwest Venture PartnersIn-Q-TelThrive CapitalCollaborative FundRA CapitalCRV (Charles River Ventures)Foundation CapitalForesite CapitalSlow VenturesSalesforce VenturesTrue VenturesKapor CapitalFounders FundCraft VenturesBenchmarkBain Capital VenturesBond Capital ManagementAtlas VentureSound VenturesFJ LabsCanaan PartnersSapphire VenturesBattery VenturesIntel CapitalGeneral AtlanticTuesday CapitalQualcomm VenturesFounder CollectiveNotable CapitalACME CapitalLiquid VenturesFloodgateScale Venture PartnersVenrockPolaris PartnersComcast VenturesWellington ManagementUncork CapitalEniac VenturesSusa VenturesRRE VenturesAmplify PartnersMatrixUnion Square Ventures (USV)Balderton CapitalMadrona Venture GroupFuel CapitalCapitalGBallistic VenturesAltimeter CapitalGreenoaksS32Deerfield Management CompanyThird Rock VenturesDST GlobalGreat Oaks Venture CapitalFirstMark CapitalGreycroftOak HC/FTAcrew CapitalSherpalo VenturesWingCoinbase VenturesWebb Investment NetworkDragoneer Investment GroupBain Capital Life SciencesBling CapitalCaffeinated CapitalObvious VenturesAdditionRibbit CapitalLowercase CapitalShasta VenturesValor Equity PartnersPlug and Play VenturesGradient VenturesAME Cloud VenturesUpfront VenturesVillage GlobalTenaya CapitalSpider CapitalHOF CapitalLudlow VenturesThe Column GroupNextech InvestStreamlined VenturesForerunner VenturesCota CapitalResolute VenturesSierra VenturesPoint NinePantera CapitalThreshold VenturesGlobal Founders CapitalChemistryNext Play VenturesDreamers VCLocus VenturesLocalGlobeVersant VenturesFoothill VenturesDolby Family VenturesAtomicoPioneerFifth WallEmergence Capital PartnersCrosslink CapitalRevolutionParadigmGoodwater CapitalDell Technologies CapitalThe Chernin Group (TCG Crypto)Standard CapitalOrbiMedThird Point VenturesPreston-Werner VenturesNGP CapitalPrelude VenturesStrawberry Creek VenturesWorkday VenturesCity LightSofinnova VenturesOptum VenturesDFJLong Journey VenturesB Capital GroupOffline VenturesMayfield FundSciFi VCFreestyle CapitalInnovation EndeavorsSignalFireMeritech Capital PartnersUlu VenturesBonfire VenturesMaveronRidge VenturesBase10 PartnersTwo Sigma VenturesAccompliceEQT VenturesEntrée CapitalNotion CapitalAugust CapitalLakestarDecibel PartnersWork-BenchAmerican Express Ventures (Amex)Nyca PartnersM12 (Microsoft's Venture Fund)NewView CapitalThomvest VenturesBow CapitalNorthpond VenturesStripeVista Venture PartnersSanofi VenturesQiming Venture PartnersS2G InvestmentsShine CapitalMercury FundKaiser Permanente VenturesOxford Science EnterprisesSOSVPICUS CAPITALKindred VenturesUncorrelated VenturesTSVCCostanoa VenturesAngelPadBetaworks Ventures Management, LlcOperator CollectiveNextGen Venture Partnersboldstart venturesScribble VenturesBedrockOurCrowdGotham Gal VenturesPeak XV PartnersTusk Venture PartnersSummit PartnersPlayground GlobalMulticoin CapitalBasis Set VenturesOrigin VenturesXfundFlare Capital PartnersGE VenturesMoonfire VenturesWalden CatalystAccenture VenturesArrivef7 VenturesAscension VenturesSlack FundvenBio PartnersFlagship Pioneering7wire VenturesThomson Reuters VenturesAisling CapitalDefine VenturesDTCPCleo CapitalForefront VentureExpaBright Pixel CapitalAccess BiotechnologySteelSky VenturesQuiet CapitalNextView VenturesFlybridge Capital PartnersBowery CapitalSouth Park CommonsPractical Venture CapitalTodd and Rahul’s Angel FundBullpen CapitalNext4701 AdvisorsHarrison MetalCreandumM13Nexus Venture PartnersGeneral PartnershipEclipse VenturesSpeedinvestDraper Fisher Jurvetson (DFJ)March Capital PartnersMaC Venture Capital468 CapitalPassion CapitalTransmedia CapitalCoinFundBreakthrough Energy VenturesAnthemis VentureAmadeus Capital PartnersContraryGolden VenturesVertex Ventures Sea Management Pte. Ltd.G2 Venture PartnersArtis VenturesGreatPoint VenturesAllegisCyber CapitalAntiKyber Knight CapitalBasecamp FundXplorer CapitalSchematic VenturesCambridge Innovation CapitalEight Roads VenturesDigitalis VenturesIngeborg InvestmentsDBL PartnersIlluminate FinancialSemperVirens Venture CapitalMaverick Capital+ND CapitalHBM PartnersBluebird VenturesPermiraUberPartech VenturesHCVCStride VCElectric CapitalTrinity VenturesDCM Ventures2048 VenturesWEEKENDKortschak Investments L.P.Bitkraft Esports VenturesTq Ventures LlcTribe CapitalOutlander VCKearny JacksonMoxxie VenturesRobot VenturesHigh AlphaSerena VenturesLead Edge CapitalPolychain CapitalAnorak VenturesCoelius CapitalMango CapitalFounders' Co-opAllison Pickens VenturesRocketship.vcGiant Ventures Global LlpJackson Square VenturesWalden InternationalK9 VenturesMMC VenturesFuture Perfect VenturesYes VCUP PartnersHelium-3 VenturesPresence CapitalParade VenturesMerus CapitalTen ElevenEvolution Equity PartnersDefy PartnersTRANSFORMATION CAPITALIncite.orgPaladin Capital GroupCherubic VenturesDimension CapitalEpisode1Sofinnova PartnersS CapitalSR One Capital ManagementToyota VenturesMVP VenturesAtlantic Bridge VenturesMPM BioImpactMithril Capital ManagementAbingworthFin CapitalAdvance Venture PartnersNovartis Venture FundOlima VenturesBryant StibelGlencrest GroupVivo CapitalSafar PartnersConductive VenturesMomenta VenturesVida VenturesData TechGrit VenturesOpenAI Startup FundThird PointiSelect FundWireframe VenturesCyber Mentor FundCarya Venture PartnersRTW Investments L.P.US Innovative TechnologyUnknown VenturesEverywhere VenturesUpHonest CapitalAccel-KKRBuckley Ventures Management Company LlcCatapult CapitalOperator LPPareto HoldingsCyberstartsHaun Ventures23andMeBrainchild HoldingsFreigeist CapitalJavelin Venture PartnersUpside PartnershipMosaic VenturesFormation GroupCrosscut VenturesHoxton Venturesfirstminute capitalZeev VenturesWhat If VenturesAdverb VenturesVoyager CapitalHighbury HoldingsSAV (Scale Asia Ventures)Thirty Five Ventures (35V)Angular VenturesVerified CapitalGlilot Capital PartnersMiramar Venture PartnersGeek VenturesCredo VenturesUprisingBand of AngelsBioGeneration VenturesKindred CapitalCongruent VenturesEqual VenturesAvalanche VCJerusalem Venture Partners (JVP)Stanford UniversityCavalry VenturesMizMaa VenturesSandbox IndustriesArboretum VenturesMorgenthalerCapnamicRoosh VenturesMerak VenturesSupernode VenturesHatteras Venture PartnersElement PartnersAirbus VenturesFundamental VenturesLumia Capital33NPale Blue DotThe Venture Reality FundVMG PartnersAcre Venture PartnersnoaRethink EducationUntapped CapitalThompson Hutton, LLCHealthCapBlueberry VenturesBloom8MicrotractionAnterra CapitalBuckhill CapitalSpacecadet VenturesCentre for Research & Technology Hellas (CERTH)KrakenGoat CapitalC2 InvestmentsPhysical IntelligenceLookout VenturesTrajectory VenturesHanabi CapitalWGI GroupCausalFootworkHV Capital7percent VenturesPelion Venture PartnersZetta Venture PartnersCherry VenturesVine Ventures2xNMucker CapitalPolygonScience VenturesProximity VenturesKohlberg Kravis Robertsfoobar.vcRecursive VenturesExpansive VenturesDig Ventures Management LimitedIVCZ47Marcy Venture PartnersJetstreamThird Kind Venture CapitalBDC Venture CapitalGutter CapitalNotation CapitalSmash CapitalVertex Ventures IsraelRavelin CapitalMorado Venture PartnersKaszek VenturesPresight CapitalVenture HighwayConvective CapitalSweet CapitalcLabsAthletico VenturesPossible VenturesAstanor VenturesIrishAngelsStealth CapitalTrucks VCAZ-VCIncisive Ventures14WRace CapitalCyfrinPrimetime PartnersHC9 VenturesJigsaw VCmuru-DPrimitive VenturesE1 Ventures8090 IndustriesCrane Venture PartnersPortage VenturesStrata Capital PartnersSyngenta Group VenturesFinch CapitalCambrian VenturesOkta VenturesTimespan VenturesCambrian Asset ManagementGSR VenturesLiveOak VenturesPiva CapitalTriatomic CapitalInvariantes FundAmara VCTelescope PartnersTwo Small Fish VenturesFramework VenturesV3 VenturesBliscePitchdriveMKT1 CapitalTalis CapitalApollo Health VenturesCreative Destruction Lab (CDL)DVx VenturesConsensys VenturesInterlock PartnersFitz Gate VenturesVensana CapitalBerkeley Angel NetworkDistributed VenturesWasabi VenturesBerkeley Blockchain XceleratorARK Investment ManagementAfterWork VenturesL'ATTITUDE VenturesLearnStartSure VenturesAqua SparkAzolla VenturesAyuh VenturesBanyan VenturesPandaDocQiming Venture Partners USASatori CapitalAlma AngelsFusion VCVree VenturesHighlandXHarvard Business School Alumni Angels of Greater New YorkRough Draft VenturesBrand Capital

Firms observed investing alongside GV (Google Ventures), from public investor directories. Shared companies are the overlap with GV (Google Ventures)'s recorded portfolio.

Similar investors

Featured in lists